Alan S. Roemer - 01 Jun 2022 Form 4/A - Amendment Insider Report for IN8BIO, INC. (INAB)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
23 Sep 2022, 17:08:15 UTC
Date Of Original Report
14 Jun 2022
Previous filing
22 Dec 2021
Next filing
15 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Stock Option (right to buy) Award $0 +13,500 $0.000000 13,500 01 Jun 2022 Common Stock 13,500 $2.24 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The original Form 4 inadvertently listed the incorrect number of shares granted to the Reporting Person.
F2 One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date.